|
|
Volumn 27, Issue 11, 2009, Pages 961-962
|
|
Pfizer settles largest ever fraud suit for off-label promotion
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALLERGEN;
GABAPENTIN;
OLANZAPINE;
VALDECOXIB;
BILLING AND CLAIMS;
DRUG INDUSTRY;
DRUG MARKETING;
FOOD AND DRUG ADMINISTRATION;
FORGERY;
LAW SUIT;
MEDICARE;
NOTE;
OFF LABEL DRUG USE;
PRIORITY JOURNAL;
DRUG INDUSTRY;
DRUG LABELING;
FRAUD;
GUIDELINES AS TOPIC;
HUMANS;
OFF-LABEL USE;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 70449368817
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1109-961 Document Type: Note |
|
Times cited : (12)
|
|
References (0)
|
